Abstract:The efficacy of different doses of oral DNA vaccines carrying VP2 gene of vvIBDV delivered by E. coli DH5alpha was studied and compared with purified VP2 recombinant expression plasmid DNA vaccine injected intradermally and whole virus vaccine either from homologous virus or from commercial source. The recombinant plasmid pRc-VP2 was transformed in a non-pathogenic strain of E. coli, the DH5alpha and designated as EC/pRC-VP2. Oral immunization of maternal antibody free broiler chickens at 7 and 14-day-old with different dosages of EC/pRc-VP2 elicited specific humoral immune response as measured by ELISA. Protection in different groups was calculated through clinical signs, gross and histopathological lesions, bursa of Fabricius to body weight ratio, humoral and cellular immune responses and mortality in the chickens. Vaccination with EC/pRc-VP2 at the dose rate of 10(9)CFU per chicken conferred 95.4% protection of the chickens against the challenge with homologous virulent field strain of vvIBDV. Protection afforded by attenuated vero cell adapted UAF-06 strain of vvIBDV was comparable (94%) to that by EC/pRc-VP2 and pRc-VP2 vaccines, which was significantly higher (P<0.05) than the protection provided by a commercial attenuated IBDV stain D-78 vaccine (D-78 vaccine was used as positive control due to its frequent use in the field for vaccination of poultry chickens) and other control groups in the study. The results revealed that DNA vaccines against IBDV may be successfully done by adopting bacterial-vectored oral delivery system and vaccination with homologous vvIBDV (UAF-06) conferred significantly higher protection as compared with imported non-homologous commercial IBDV vaccine.

Recombinant MDV Expressing Vp2 Gene of Infectious Bursal Disease Virus (IBDV) Induced Protection Against Virulent IBDV in Chickens with or Without Maternal Antibodies

Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.

Induction of Protective Immune Response in Chickens Immunized with Plasmid DNA Encoding Antigens of Infectious Bursal Disease Virus

Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.

Enhancement of the Immunogenicity of DNA Vaccine Against Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin 2.

The Immunogenicity of CO-expressing Plasmid and Fusion Genes Plasmid Containing IBDV VP2/4/3 and ChIL-18 Genes

Study on the Immunogenicity of Infectious Bursal Disease Virus VP2 Proteins Expressed in Silkworm

Synthesis of Reassortant Infectious Bursal Disease Virus in Chickens Injected Directly with Infectious Clones from Different Virus Strains

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

Immunoenhancement on DNA Vaccine of Polyprotein Gene in Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin-18.

Immunoenhancement on IBDV DNA vaccine by embryo vaccination with plasmid DNA encoding chicken interleukin-18

[Enhanced Immunogenicity of Plasmid Encoding Polyprotein Gene of Infectious Bursal Disease Virus by Co-Administration of Chicken Interleukin 2 (IL-2)].

Generation of VP5 deficient mutant of infectious bursal disease virus strain HZ2

Recombinant Lactococcus Expressing a Novel Variant of Infectious Bursal Disease Virus VP2 Protein Can Induce Unique Specific Neutralizing Antibodies in Chickens and Provide Complete Protection

Recombinant Marek's disease virus type 1 provides full protection against H9N2 influenza A virus in chickens

A Single Vaccination of IBDV Subviral Particles Generated by Kluyveromyces marxianus Efficiently Protects Chickens against Novel Variant and Classical IBDV Strains

Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by attenuated Salmonella elicits protective immune responses in chickens

[Expression of the Infectious Bursal Disease Virus Polyprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier].

Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen

DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens

DNA vaccination with VP2 gene fragment confers protection against Infectious Bursal Disease Virus in chickens